Skip to content

German Diabetes-Diet-Intervention and Energy Restriction-Trial (DDIET)

Short Term Diet Intervention in Newly Diagnosed Type 2 Diabetes. a Randomised, Multicentric, Controlled, Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01409330
Acronym
DDIET
Enrollment
40
Registered
2011-08-04
Start date
2011-02-28
Completion date
2013-12-31
Last updated
2023-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Keywords

insulin sensitivity, type 2 diabetes, diet intervention

Brief summary

Diet intervention according to the German Diabetes Risk Score in newly diagnosed type 2 diabetes. This study aims to explore the effect of diet lacking red meat, but containing increased fibers and coffee (verum) versus standard recommendation (control) in a multicenter setting.

Detailed description

This study is a randomised, multicenter controlled trial Our Aim is to test the effects of an 8-week diet lacking red meat, containing increased fibers and coffee (verum) versus standard recommendation (control)in a multicenter setting. We are expecting that the verum diet will improve insulin sensitivity and insulin secretion due to reductions in visceral and hepatic fat along with improved adipocyte cytokine secretion profiles

Interventions

DIETARY_SUPPLEMENTdiet intervention

8-week diet lacking red meat, but containing increased fibers and coffee (verum) versus standard recommendation (control) eating red meat.

Sponsors

German Diabetes Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 69 Years
Healthy volunteers
No

Inclusion criteria

* Type 2 diabetic patients * disease duration for five years or less, * age of 69 years or less, * body mass index of 30 kg/m2 or more, * hemoglobin A1c of 5,5 % to 9% * patient should be on standard diet or metformin +/- acarbose monotherapy * patient should be without

Exclusion criteria

for coffee consumption

Design outcomes

Primary

MeasureTime frameDescription
whole body insulin sensitivity8 weeksmeasurement of whole body insulin sensitivity with hyperinsulinamic euglicamic clamp

Secondary

MeasureTime frameDescription
intramyocellular lipids8 weeksMRS measurement to investigate the effects of diet intervention on ectopic lipid content in skeletal muscle
skeletal muscle mitochondrial function - insulin signaling8 weeksmuscle biopsy for assessment of insulin signaling
hepatocellular lipids8 weeksMRS measurement to investigate the effects of diet intervention on ectopic lipid content in liver(HCL)
total body fat8 weeksMRI measurement of the effects of 8-week diet intervention on total body fat
insulin secretion8 weeksmeasurement of insulin secretion with glucagon test, mixed-meal test and intravenous glucose tolerance test
pancreatic fat8 weeksMRI measurement of the effects of 8-week diet intervention on pancreatic fat
skeletal muscle mitochondrial function - phosphate-recovery time8 weeksskeletal muscle mitochondrial function in vivo assessed as phosphate-recovery time with MRS

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 19, 2026